Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma.

Saved in:
Bibliographic Details
Title: Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma.
Authors: Rivera B; Department of Human Genetics, McGill University, Montreal, Canada.; Lady Davis Institute, Montreal, Canada., Di Iorio M; Department of Human Genetics, McGill University, Montreal, Canada., Frankum J; The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Nadaf J; Department of Human Genetics, McGill University, Montreal, Canada.; Genome Quebec Innovation Centre, Montreal, Canada., Fahiminiya S; Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, Canada., Arcand SL; Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, Canada., Burk DL; Department of Biochemistry, McGill University, Montreal, Canada., Grapton D; Lady Davis Institute, Montreal, Canada., Tomiak E; Department of Genetics, University of Ottawa, Children's Hospital of Eastern Ontario, Canada., Hastings V; Department of Genetics, University of Ottawa, Children's Hospital of Eastern Ontario, Canada., Hamel N; Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, Canada., Wagener R; Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Ulm, Germany., Aleynikova O; Department of pathology, Jewish General Hospital, Montreal, Canada., Giroux S; University of Laval and CHU Research Centre, Quebec; Canada., Hamdan FF; CHU Sainte-Justine Research Center, Montreal, Canada., Dionne-Laporte A; Montreal Neurological Institute, McGill University, Montreal, Canada., Zogopoulos G; Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, Canada.; The Goodman Cancer Research Centre, McGill University, Montreal, Canada., Rousseau F; University of Laval and CHU Research Centre, Quebec; Canada., Berghuis AM; Department of Biochemistry, McGill University, Montreal, Canada., Provencher D; Centre de recherche du CHUM and Institut du cancer de Montréal, University of Montreal, Montreal, Canada., Rouleau GA; Montreal Neurological Institute, McGill University, Montreal, Canada., Michaud JL; CHU Sainte-Justine Research Center, Montreal, Canada., Mes-Masson AM; Centre de recherche du CHUM and Institut du cancer de Montréal, University of Montreal, Montreal, Canada., Majewski J; Department of Human Genetics, McGill University, Montreal, Canada.; Genome Quebec Innovation Centre, Montreal, Canada., Bens S; Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Ulm, Germany., Siebert R; Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Ulm, Germany., Narod SA; Dalla Lana School of Public Health, Toronto, Canada.; Women's College Hospital, Toronto, Canada., Akbari MR; Dalla Lana School of Public Health, Toronto, Canada.; Women's College Hospital, Toronto, Canada., Lord CJ; The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Tonin PN; Department of Human Genetics, McGill University, Montreal, Canada.; Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, Canada.; Department of Medicine, McGill University, Montreal, Canada., Orthwein A; Lady Davis Institute, Montreal, Canada.; Department of Oncology, McGill University, Montreal, Canada., Foulkes WD; Department of Human Genetics, McGill University, Montreal, Canada. william.foulkes@mcgill.ca.; Lady Davis Institute, Montreal, Canada.; Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, Canada.; Department of Medical Genetics, Research Institute, McGill University Health Centre, Montreal, Canada.
Source: Cancer research [Cancer Res] 2017 Aug 15; Vol. 77 (16), pp. 4517-4529. Date of Electronic Publication: 2017 Jun 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-17-0190